(Q37757220)

22 August 2017

Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia (English)

1 reference

22 August 2017

0 references

0 references

0 references

visceral leishmaniasis

1 reference

David G Lalloo

5

0 references

Luis E. Cuevas

object named as

Luis E Cuevas

6

0 references

Asrat Hailu

7

object named as

Asrat Hailu

1 reference

22 August 2017

Zewdu Hurissa

1

1 reference

22 August 2017

Samuel Gebre-Silassie

2

1 reference

22 August 2017

Workagegnehu Hailu

3

1 reference

22 August 2017

Tewodros Tefera

4

1 reference

22 August 2017

language of work or name

1 reference

14 May 2010

1 reference

Tropical Medicine and International Health

22 August 2017

1 reference

22 August 2017

15

1 reference

22 August 2017

848-855

1 reference

22 August 2017

7

1 reference

The relationship between leishmaniasis and AIDS: the second 10 years

22 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

HIV viral load and response to antileishmanial chemotherapy in co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Efficacy of intermittent liposomal amphotericin B in the treatment of visceral leishmaniasis in patients infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Visceral leishmaniasis and HIV in Tigray, Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative Group for the Study of Leishmaniasis in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

The pathogenesis of Leishmania/HIV co-infection: cellular and immunological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Visceral leishmaniasis in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients. A comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Evaluation and implementation of rapid HIV tests: the experience in 11 African countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

A comparison of miltefosine and sodium stibogluconate for treatment of visceral leishmaniasis in an Ethiopian population with high prevalence of HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

HIV and Leishmania coinfection: a review of 91 cases with focus on atypical locations of Leishmania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Visceral leishmaniasis in those infected with HIV: clinical aspects and other opportunistic infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

Aminosidine (paromomycin) in the treatment of leishmaniasis imported into the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-3156.2010.02550.X

10.1111/J.1365-3156.2010.02550.X

21 January 2018

Identifiers

DOI

1 reference

release_mfjdtui3nveifj4466qr7l3oz4

22 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mfjdtui3nveifj4466qr7l3oz4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference